Multiresistant Extended-Spectrum β-Lactamase-Producing Klebsiella pneumoniae Causing an Outbreak of Nosocomial Bloodstream Infection

Infection Control

Volumn 22, Issue 11, 2001, Pages 723-725

  Gonzalez Vertiz, Artemio ^a   Alcantar Curiel, Dolores ^a   Cuauhtli, Marcela ^a   Daza, Carlos ^a   Gayosso, Catalina ^a   Solache, Graciela ^a   Horta, Cruz ^a   Mejia, Francisco ^a   Santos, Jose I ^a   Alpuche Aranda, Celia ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPICILLIN; BETA LACTAMASE; CEFOTAXIME; CEFTAZIDIME; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; GENTAMICIN;

ARTICLE; BACTERIAL TRANSMISSION; DISEASE CARRIER; DISEASE CONTROL; EPIDEMIC; HOSPITAL INFECTION; HUMAN; INTESTINE; KLEBSIELLA PNEUMONIAE; MEXICO; MULTIDRUG RESISTANCE; SEPTICEMIA;

ANTI-BACTERIAL AGENTS; BACTEREMIA; BACTERIAL TYPING TECHNIQUES; BETA-LACTAMASES; CROSS INFECTION; DISEASE OUTBREAKS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HOSPITALS, GENERAL; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MEXICO;

EID: 0035707201     PISSN: 01959417     EISSN: 23279451     Source Type: Journal    
DOI: 10.1017/S0195941700072738     Document Type: Article

References (13)

1. Eisenstein BI, Zaleznic DF. Enterobacteriaceae. In: Principles and Practice of Infectious Diseases. 5th ed. Sidup, Kent, UK: Churchill Livingstone; 2000:2294–2310.
2. Jacoby GA. Extended-spectrum β-lactamases and other enzymes provided resistance to oxyimino-β-lactams. Infect Dis Clin North Am 1997;11:875–887.
3. Rice LB, Willey SH, Papanicolaou GA, Medeiros AA, Eliopoulos GM, Moellering RC Jr, et al. Outbreak of ceftazidime resistance caused by extended-spectrum β-lactamases at a Massachusetts chronic-care facility. Antimicrob Agents Chemother 1990;34:2193–2199.
4. Rios-Martinez C, Guerrero-Camacho A, Machuca-Becerril O, Miranda-Novales G, Solorzano-Santos F, Reyes-Vega S, et al. Brote por Klebsiella pneumoniae multirresistente en una unidad de cuidados neonatales.
5. Análisis epidemiológico y molecular. In: Program and Abstracts of the 25th Congreso Anual de la Asociación Mexicana de Infectologia y Microbiologia Clinica; León, Guanajuato, Mexico; June 28-July 1, 2000. Abstract 159.
6. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections. In: Olmsted RN, ed. APIC Infection Control and Applied Epidemiology: Principles and Practices. St. Louis, MO: Mosby; 1996:A1-A20.
7. National Committee for Clinical Laboratory Standards 2000. Methods for Dilution Antimicrobial Susceptibility Test for Bacteria That Grow Aerobically. 5th ed. Wayne, PA: National Committee for Clinical Laboratory Standards; 2000.
8. Goering R. Molecular epidemiology of nosocomial infection: analysis of chromosomal restriction fragment patterns by pulsed-field gel electrophoresis. Infect Control Hosp Epidemiol 1993;14:595–600.
9. Miller JH. Experiments in Molecular Genetics. New York, NY: Cold Spring Harbor Laboratory; 1972:387.
10. Mathew M, Harris AM, Marshall MJ, Ross GW. The use of analytical isoelectric focusing for detection and identification of β-lactamases. J Gen Microbiol 1975;88:169–178.
11. Jarvis WR. The epidemiology of colonization. Infect Control Hosp Epidemiol 1996;17:47–52.
12. Silva J, Aguilar C, Ayala G, Estrada MA, Garze-Ramos U, Lara-Lemus R, et al. TLA-1: a new plasmid-mediated extended-spectrum β-lactamase from Escherichia coli. Antimicrob Agents Chemother 2000;44:997–1003.
13. Winokur PL, Canton R, Casellas JM, Legakis N. Variations in the prevalence of strains expressing an extended spectrum β-lactamase phenotype and characterization of isolates from Europe, the Americas and the Western Pacific Region. Clin Infect Dis 2001;32(suppl 2):S94-S103.